Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 12, 2016 - Issue
Submit an article Journal homepage
48
Views
5
CrossRef citations to date
0
Altmetric
Review

Spotlight on afatinib and its potential in the treatment of squamous cell lung cancer: the evidence so far

Yijun Xu1 Thoracic Oncology Program, Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA;2 Tianjin Chest Hospital, Tianjin, People’s Republic of China
,
Vivianne W Ding1 Thoracic Oncology Program, Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA
,
Hong Zhang2 Tianjin Chest Hospital, Tianjin, People’s Republic of China
,
Xun Zhang2 Tianjin Chest Hospital, Tianjin, People’s Republic of China
,
David Jablons1 Thoracic Oncology Program, Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA
&
Biao He1 Thoracic Oncology Program, Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USACorrespondence[email protected]
Pages 807-816 | Published online: 24 May 2016

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Shuangjiang Li, Zhiqiang Wang, Kun Zhou, Yan Wang, Yanming Wu, Pengfei Li & Guowei Che. (2018) Effects of degree of pulmonary fissure completeness on major in-hospital outcomes after video-assisted thoracoscopic lung cancer lobectomy: a retrospective-cohort study. Therapeutics and Clinical Risk Management 14, pages 461-474.
Read now
Marco Tagliamento, Carlo Genova, Erika Rijavec, Giovanni Rossi, Federica Biello, Maria Giovanna Dal Bello, Angela Alama, Simona Coco, Simona Boccardo & Francesco Grossi. (2018) Afatinib and Erlotinib in the treatment of squamous-cell lung cancer. Expert Opinion on Pharmacotherapy 19:18, pages 2055-2062.
Read now
Ana P. S. Silva, Priscila V. Coelho, Maristella Anazetti & Patricia U. Simioni. (2017) Targeted therapies for the treatment of non-small-cell lung cancer: Monoclonal antibodies and biological inhibitors. Human Vaccines & Immunotherapeutics 13:4, pages 843-853.
Read now

Articles from other publishers (2)

Lei Pan, Fanqi Meng, Wei Wang, Xu-hao Wang, Hui Shen, Pengchen Bao, Jian Kang & Delei Kong. (2023) Nintedanib in an elderly non-small-cell lung cancer patient with severe steroid-refractory checkpoint inhibitor-related pneumonitis: A case report and literature review. Frontiers in Immunology 13.
Crossref
A. Lakshmipriya, Madhusudan Chaudhary, Santosh Mogurampelly, Michael L. Klein & N. Suryaprakash. (2018) Intramolecular Hydrogen Bonding Appetency for Conformational Penchants in Oxalohydrazide Fluoro Derivatives: NMR, MD, QTAIM, and NCI Studies. The Journal of Physical Chemistry A 122:10, pages 2703-2713.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.